methotrexate

Generic: methotrexate

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name methotrexate
Generic Name methotrexate
Labeler chartwell rx, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

methotrexate sodium 2.5 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-772
Product ID 62135-772_462a5023-e5a1-692a-e063-6294a90a7236
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210454
Listing Expiration 2026-12-31
Marketing Start 2020-01-30

Pharmacologic Class

Classes
folate analog metabolic inhibitor [epc] folic acid metabolism inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135772
Hyphenated Format 62135-772

Supplemental Identifiers

RxCUI
105585
UPC
0362135772352
UNII
3IG1E710ZN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name methotrexate (source: ndc)
Generic Name methotrexate (source: ndc)
Application Number ANDA210454 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
source: ndc
Packaging
  • 36 TABLET in 1 BOTTLE (62135-772-35)
source: ndc

Packages (1)

Ingredients (1)

methotrexate sodium (2.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "462a5023-e5a1-692a-e063-6294a90a7236", "openfda": {"upc": ["0362135772352"], "unii": ["3IG1E710ZN"], "rxcui": ["105585"], "spl_set_id": ["2609da8f-80dc-448e-8eba-35d11488ce7f"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "36 TABLET in 1 BOTTLE (62135-772-35)", "package_ndc": "62135-772-35", "marketing_start_date": "20230829"}], "brand_name": "Methotrexate", "product_id": "62135-772_462a5023-e5a1-692a-e063-6294a90a7236", "dosage_form": "TABLET", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "62135-772", "generic_name": "Methotrexate", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Methotrexate", "active_ingredients": [{"name": "METHOTREXATE SODIUM", "strength": "2.5 mg/1"}], "application_number": "ANDA210454", "marketing_category": "ANDA", "marketing_start_date": "20200130", "listing_expiration_date": "20261231"}